Camille Doykan

4.3k total citations · 1 hit paper
9 papers, 2.6k citations indexed

About

Camille Doykan is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Camille Doykan has authored 9 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Immunology. Recurrent topics in Camille Doykan's work include Immune cells in cancer (4 papers), Acute Myeloid Leukemia Research (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Camille Doykan is often cited by papers focused on Immune cells in cancer (4 papers), Acute Myeloid Leukemia Research (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Camille Doykan collaborates with scholars based in United States, Canada and Austria. Camille Doykan's co-authors include Pauline Wu, Howard L. Weiner, Oleg Butovsky, Amanda J. Lanser, Galina Gabriely, Zain Fanek, Mark P. Jedrychowski, Ron Cialic, Steven P. Gygi and Thomas Koeglsperger and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Nature Neuroscience.

In The Last Decade

Camille Doykan

9 papers receiving 2.6k citations

Hit Papers

Identification of a uniqu... 2013 2026 2017 2021 2013 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Identification of a unique TGF-β–dependent molecular and functional signature in microglia
    2013 1.9k citations Oleg Butovsky, Mark P. Jedrychowski et al. Nature Neuroscience profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Camille Doykan United States 7 1.9k 1.1k 619 446 432 9 2.6k
Pauline Wu United States 3 1.9k 1.0× 1.1k 1.0× 586 0.9× 445 1.0× 432 1.0× 5 2.5k
Amanda J. Lanser United States 7 1.8k 1.0× 1.2k 1.1× 523 0.8× 362 0.8× 391 0.9× 8 2.5k
Zain Fanek United States 3 1.7k 0.9× 1.0k 0.9× 495 0.8× 233 0.5× 381 0.9× 6 2.2k
Karpagam Srinivasan United States 16 1.1k 0.6× 514 0.5× 949 1.5× 228 0.5× 733 1.7× 16 2.4k
John V. Pluvinage United States 11 927 0.5× 617 0.6× 759 1.2× 99 0.2× 483 1.1× 14 2.0k
Christian U.A. Kloss Germany 17 1.2k 0.6× 453 0.4× 475 0.8× 287 0.6× 214 0.5× 26 1.9k
Anna Erlandsson Sweden 26 845 0.4× 179 0.2× 967 1.6× 706 1.6× 805 1.9× 58 2.4k
Patrick Burrola United States 19 587 0.3× 893 0.8× 851 1.4× 192 0.4× 548 1.3× 24 2.5k
Jerome R. Wujek United States 15 679 0.4× 430 0.4× 505 0.8× 223 0.5× 405 0.9× 17 2.2k
Marion Bohatschek Germany 14 817 0.4× 346 0.3× 551 0.9× 191 0.4× 228 0.5× 16 1.8k

Countries citing papers authored by Camille Doykan

Since Specialization
Citations

This map shows the geographic impact of Camille Doykan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camille Doykan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camille Doykan more than expected).

Fields of papers citing papers by Camille Doykan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Camille Doykan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camille Doykan. The network helps show where Camille Doykan may publish in the future.

Co-authorship network of co-authors of Camille Doykan

This figure shows the co-authorship network connecting the top 25 collaborators of Camille Doykan. A scholar is included among the top collaborators of Camille Doykan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camille Doykan. Camille Doykan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Smith, B. Douglas, Steven L. Warner, Clifford J. Whatcott, et al.. (2015). An alvocidib-containing regimen is highly effective in AML patients through a mechanism dependent on MCL1 expression and function.. Journal of Clinical Oncology. 33(15_suppl). 7062–7062. 8 indexed citations
2.
Butovsky, Oleg, Mark P. Jedrychowski, Craig S. Moore, et al.. (2015). ISDN2014_0027: REMOVED: Identification of a unique molecular and functional microglia signature in health and disease. International Journal of Developmental Neuroscience. 47(Part_A). 5–5. 1 indexed citations
3.
Dettman, Elisha J., Steven L. Warner, Camille Doykan, et al.. (2015). Abstract 3400: Mitochondrial profiling in AML patients treated with an Alvocidib containing regimen reveals MCL1 dependency in responder bone marrow. Cancer Research. 75(15_Supplement). 3400–3400. 6 indexed citations
4.
Narayan, Rupa, Jacqueline S. Garcia, Mary‐Elizabeth M. Percival, et al.. (2015). Sequential azacitidine plus lenalidomide in previously treated elderly patients with acute myeloid leukemia and higher risk myelodysplastic syndrome. Leukemia & lymphoma. 57(3). 609–615. 18 indexed citations
5.
Butovsky, Oleg, Mark P. Jedrychowski, Ron Cialic, et al.. (2015). ISDN2014_0028: REMOVED: Targeting miR‐155 restores dysfunctional microglia and ameliorates disease in the SOD1 model of ALS. International Journal of Developmental Neuroscience. 47(Part_A). 5–5. 2 indexed citations
6.
Pierceall, William E., Bruno C. Medeiros, Camille Doykan, et al.. (2014). Mcl-1 dependence predicts response to vorinostat and gemtuzumab ozogamicin in acute myeloid leukemia. Leukemia Research. 38(5). 564–568. 11 indexed citations
7.
Butovsky, Oleg, Mark P. Jedrychowski, Ron Cialic, et al.. (2014). Targeting miR‐155 restores abnormal microglia and attenuates disease in SOD1 mice. Annals of Neurology. 77(1). 75–99. 285 indexed citations
8.
Butovsky, Oleg, Mark P. Jedrychowski, Craig S. Moore, et al.. (2013). Identification of a unique TGF-β–dependent molecular and functional signature in microglia. Nature Neuroscience. 17(1). 131–143. 1872 indexed citations breakdown →
9.
Butovsky, Oleg, Shafiuddin Siddiqui, Galina Gabriely, et al.. (2012). Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. Journal of Clinical Investigation. 122(9). 3063–3087. 381 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pauline Wu Breakdown of academic impact, for papers by Amanda J. Lanser Breakdown of academic impact, for papers by Zain Fanek Breakdown of academic impact, for papers by Karpagam Srinivasan Breakdown of academic impact, for papers by John V. Pluvinage Breakdown of academic impact, for papers by Christian U.A. Kloss Breakdown of academic impact, for papers by Anna Erlandsson Breakdown of academic impact, for papers by Patrick Burrola Breakdown of academic impact, for papers by Jerome R. Wujek Breakdown of academic impact, for papers by Marion Bohatschek
Rankless by CCL
2026